55630-08-5

Upstream product

• 56737-17-8 N-(2,2,2-trichloro-1-hydroxyethyl)-4-chlorobenzamide 
• 53998-66-6 p-chlorobenzoic acid 1,2,2,2-tetrachloroethylamide 
• 603-35-0 triphenylphosphine 

Downstream Products

• 55630-22-3 [2-(4-chloro-phenyl)-5-morpholin-4-yl-oxazol-4-yl]-triphenyl-phosphonium; iodide 
• 55630-21-2 [2-(4-chloro-phenyl)-5-dimethylamino-oxazol-4-yl]-triphenyl-phosphonium; iodide 
• 76621-66-4 1-p-chlorobenzoylamino-2,2-di(p-chlorophenylthio)ethenyltriphenylphosphonium chloride 
• 76621-58-4 2-(4-chlorophenyl-5-thioxo-2-oxazolin-4-ylidene)triphenylphosphorane 
• 76621-55-1 C₂₇H₁₉Cl₃NOP 
• 137554-32-6 [(E)-2-Chloro-1-(4-chloro-benzoylamino)-2-(4-chloro-phenylsulfanyl)-vinyl]-triphenyl-phosphonium; chloride 
• 76621-70-0 {2,2-Dichloro-1-[(4-chloro-benzoyl)-methyl-amino]-vinyl}-triphenyl-phosphonium; iodide 

Relevant academic research and scientific papers

In silico and in vitro studies of a number PILs as new antibacterials against MDR clinical isolate Acinetobacter baumannii

QSAR analysis of a set of previously synthesized phosphonium ionic liquids (PILs) tested against Gram-negative multidrug-resistant clinical isolate Acinetobacter baumannii was done using the Online Chemical Modeling Environment (OCHEM). To overcome the pr

New 1,3-oxazolylphosphonium salts as potential biocides: QSAR study, synthesis, antibacterial activity and toxicity evaluation

Background: Due to the increase of multidrug-resistant microorganisms, the search for biologically active molecules does not stop. In the present study, we developed the effective QSAR model which allows a quick search of new potential Staphylococcus aure